Skip to main content

Rocket Pharmaceuticals, Inc.

RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001281895

In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of RCKT: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders1921225+34
Shares92.7M34.4K109.6M+17.0M (+18.3%)
Value$1.71B$635.7K$1.38B−$331.2M (−19.4%)

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (59)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to RCKT in Q4 2024
InstitutionSharesValue% of portfolio
Suvretta Capital Management, LLC2,566,951$32.3M1.20%
Boxer Capital Management, LLC1,466,051$18.4M1.57%
Avoro Capital Advisors LLC1,200,000$15.1M0.21%
Toronto Dominion Bank1,100,000$13.8M0.03%
Siren, L.L.C.600,000$7.54M0.33%
Voss Capital, LLC421,700$5.30M0.39%
Soleus Capital Management, L.P.271,659$3.41M0.26%
StemPoint Capital LP270,983$3.41M0.85%
Renaissance Technologies LLC218,519$2.75M0.00%
Ovata Capital Management Ltd200,000$2.51M0.96%
Exome Asset Management LLC159,552$2.01M1.51%
Sovran Advisors, LLC150,767$1.57M0.22%
Baker Bros. Advisors LP97,079$1.22M0.01%
Tema ETFs LLC90,985$1.14M0.47%
Creative Planning88,844$1.12M0.00%
LMR Partners LLP75,000$942.8K0.02%
Natixis48,400$608.4K0.00%
Prelude Capital Management, LLC47,247$593.9K0.05%
Algert Global LLC40,060$503.6K0.01%
one8zero8, LLC39,700$499.0K0.11%
Alyeska Investment Group, L.P.30,312$381.0K0.00%
Bayesian Capital Management, LP29,536$371.3K0.05%
Cubist Systematic Strategies, LLC28,441$357.5K0.01%
EntryPoint Capital, LLC24,903$313.0K0.13%
Sherbrooke Park Advisers LLC23,193$291.5K0.09%
Raymond James Financial Inc22,645$284.6K0.00%
Skandinaviska Enskilda Banken AB (publ)22,967$276.3K0.00%
Quest Partners LLC21,686$272.6K0.04%
Cornerstone Select Advisors, LLC19,045$239.4K0.23%
Marex Group plc17,500$220.0K0.00%
Aristides Capital LLC17,400$218.7K0.07%
JustInvest LLC17,382$218.5K0.00%
Wolverine Trading, LLC17,588$211.6K0.00%
KLP Kapitalforvaltning AS15,300$192.3K0.00%
Police & Firemen's Retirement System of New Jersey14,688$184.6K0.00%
Private Advisor Group, LLC13,199$165.9K0.00%
Thompson Siegel & Walmsley LLC12,747$160.0K0.00%
Quantinno Capital Management LP12,014$151.0K0.00%
Mariner, LLC11,061$139.0K0.00%
E Fund Management Co., Ltd.11,054$138.9K0.01%
Caitong International Asset Management Co., Ltd5,958$74.9K0.07%
GF Fund Management Co. Ltd.1,914$24.1K0.00%
Caption Management, LLC681$8.56K0.00%
Skopos Labs, Inc.374$4.70K0.00%
R Squared Ltd300$3.77K0.00%
Meeder Asset Management Inc269$3.38K0.00%
Versant Capital Management, Inc198$2.49K0.00%
SRS Capital Advisors, Inc.120$1.51K0.00%
Global Retirement Partners, LLC90$1.13K0.00%
EverSource Wealth Advisors, LLC87$1.09K0.00%
Avion Wealth146$1.00K0.00%
UMA Financial Services, Inc.79$9940.00%
Cassady Schiller Wealth Management, LLC62$7790.00%
SBI Securities Co., Ltd.50$6290.00%
MRP Capital Investments, LLC50$6290.00%
Riverview Trust Co40$5030.00%
Massmutual Trust Co FSB34$4270.00%
IFP Advisors, Inc14$1760.00%
WealthTrak Capital Management LLC10$1260.00%

Sold out (25)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (1)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RCKT in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
B. Metzler seel. Sohn & Co. Holding AG34,418$635.7K